Dose intensity or monoclonal antibody in first-line treatment

被引：4

作者：

Coiffier, B ^{[1
]}

机构：

[1] Ctr Hosp Lyon Sud, F-69310 Pierre Benite, France

来源：

HEMATOLOGY JOURNAL | 2004年 / 5卷

关键词：

D O I：

10.1038/sj.thj.6200443

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：S154 / S158

页数：5

共 34 条

[1] Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate- and high-grade lymphoma: A phase II study of the Southwest Oncology Group (SWOG 9349) [J].

Blayney, DW ;

LeBlanc, ML ;

Grogan, T ;

Gaynor, ER ;

Chapman, RA ;

Spiridonidis, CH ;

Taylor, SA ;

Bearman, SI ;

Miller, TP ;

Fisher, RI .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (13) :2466-2473

[2]

Bosly A, 2001, Hematol J, V2, P279, DOI 10.1038/sj.thj.6200116

[3] SUPERIORITY OF 2ND OVER 1ST GENERATION CHEMOTHERAPY IN A RANDOMIZED TRIAL FOR STAGE-III-IV INTERMEDIATE AND HIGH-GRADE NON-HODGKIN LYMPHOMA (NHL) - THE 1980-1985 EORTC TRIAL [J].

CARDE, P ;

MEERWALDT, JH ;

VANGLABBEKE, M ;

SOMERS, R ;

MONCONDUIT, M ;

THOMAS, J ;

DEWOLFPEETERS, C ;

DEPAUW, B ;

TANGUY, A ;

KLUINNELEMANS, JC ;

NOORDIJK, EM ;

REGNIER, R ;

BRON, D ;

LUSTMANMARECHAL, J ;

CAILLOU, B ;

BOSQ, J ;

VANHEERDE, P ;

VANUNNIK, JAM ;

BURGERS, JMV ;

HAYAT, M ;

COSSET, JM ;

VANDERSCHUEREN, E ;

WAGENER, J ;

HAGENBEEK, A ;

CATTAN, A ;

DUEZ, N ;

TUBIANA, M .

ANNALS OF ONCOLOGY, 1991, 2 (06) :431-435

[4] LNH-84 REGIMEN - A MULTICENTER STUDY OF INTENSIVE CHEMOTHERAPY IN 737 PATIENTS WITH AGGRESSIVE MALIGNANT-LYMPHOMA [J].

COIFFIER, B ;

GISSELBRECHT, C ;

HERBRECHT, R ;

TILLY, H ;

BOSLY, A ;

BROUSSE, N .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (08) :1018-1026

[5] CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. [J].

Coiffier, B ;

Lepage, E ;

Brière, J ;

Herbrecht, R ;

Tilly, H ;

Bouabdallah, R ;

Morel, P ;

Van den Neste, E ;

Salles, G ;

Gaulard, P ;

Reyes, F ;

Gisselbrecht, C .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (04) :235-242

[6] 14 YEARS OF HIGH-DOSE CHOP (ACVB REGIMEN) - PRELIMINARY CONCLUSIONS ABOUT THE TREATMENT OF AGGRESSIVE-LYMPHOMA PATIENTS [J].

COIFFIER, B .

ANNALS OF ONCOLOGY, 1995, 6 (03) :211-217

[7]

COIFFIER B, 2003, ASCO ED BOOK SPR, P606

[8]

Coiffier Bertrand, 2003, Curr Hematol Rep, V2, P23

[9]

COLTMAN CA, 1986, UPDATE TREATMENT DIF, P71

[10] RANDOMIZED COMPARISON OF MACOP-B WITH CHOP IN PATIENTS WITH INTERMEDIATE-GRADE NON-HODGKINS-LYMPHOMA [J].

COOPER, IA ;

WOLF, MM ;

ROBERTSON, TI ;

FOX, RM ;

MATTHEWS, JP ;

STONE, JM ;

DING, JC ;

DART, G ;

MATTHEWS, J ;

FIRKIN, FC ;

LOWENTHAL, RM ;

IRONSIDE, P .

JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (04) :769-778

← 1 2 3 4 →